Probing the new strategy for the oral formulations of taxanes: changing the method with the situation.

Wang, He-Lin; Sun, Jin; Tian, Chu-Tong; He, Zhong-Gui

Wang, He-Lin; Sun, Jin; Tian, Chu-Tong; He, Zhong-Gui.

Afiliação

Wang HL; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Sun J; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: sunjin@syphu.edu.cn.
Tian CT; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: TianCT_SPU@126.com.
He ZG; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

Chin J Nat Med ; 19(9): 656-665, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34561076

Assuntos

Antineoplásicos Fitogênicos; Antineoplásicos; Docetaxel; Composição de Medicamentos; Paclitaxel; Taxoides

Palavras-chave

Anti-tumor; Oral bioavailability; Oral delivery; Taxanes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos / Antineoplásicos Fitogênicos Idioma: En Revista: Chin J Nat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google